QIAGEN files lawsuit against bioMérieux to defend QuantiFERON patents and innovation in TB diagnostics

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has initiated legal proceedings against bioMérieux S.A. (EPA: BIM) in the German Unified Patent Court, marking a ... Read More